NCT05111002View on ClinicalTrials.gov

Lefamulin for M. Genitalium Treatment Failures

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions

Mycoplasma Genitalium Infection

Interventions

DRUG

Lefamulin

600mg tablet orally twice daily

DRUG

Doxycycline

100mg tablet orally twice daily

Trial Locations (1)

98195

University of Washington, Seattle

Sponsors

Collaborators (1)

Nabriva Therapeutics AG

All Listed Sponsors

collaborator

Nabriva Therapeutics AG

INDUSTRY

lead

University of Washington

OTHER